{"id":"W2500482667","doi":"10.1182/blood-2016-02-699850","title":"Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Complete remission; Gastroenterology; Hodgkin lymphoma; Chemotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001789879,0.000149369,0.00036103,0.00006948241,0.00002107842,0.000005038181,0.00004844607,0.00007639699,0.00002897298],"category_scores_gemma":[0.0003113856,0.00007576846,0.00003808229,0.0001215291,0.0001003112,0.00006683552,0.00003770688,0.00002968008,0.000008688475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009426856,"about_ca_system_score_gemma":0.0001292484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002307335,"about_ca_topic_score_gemma":0.0001440821,"domain_scores_codex":[0.9987844,0.00007684559,0.0003328586,0.0003371824,0.0002752671,0.0001934928],"domain_scores_gemma":[0.9990276,0.0002731256,0.0001316141,0.000370813,0.00009403578,0.0001028848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006285593,0.007498015,0.9730527,0.00004806745,0.0001015576,0.00004882372,0.0001386455,3.253616e-8,0.0001590454,0.00002293866,0.00008610579,0.01255845],"study_design_scores_gemma":[0.1053387,0.002524815,0.8885709,0.0003087362,0.0001136165,0.000004626056,0.00003971226,3.178932e-7,0.002783501,0.00001164555,0.0002099723,0.00009344917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983736,0.0000667093,3.958193e-7,0.0002554831,0.00004678572,0.0003946138,0.0001129419,0.00002000412,0.0007295131],"genre_scores_gemma":[0.9994281,0.000061938,0.0002277294,0.00001769847,0.00002219242,0.00001998515,0.00002213421,0.0000153224,0.0001848989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0990531,"threshold_uncertainty_score":0.3089748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009244482184418111,"score_gpt":0.2231038739298464,"score_spread":0.2138593917454283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}